Vtv Therapeutics Stock Revenue
| VTVT Stock | USD 25.50 0.52 2.08% |
vTv Therapeutics fundamentals help investors to digest information that contributes to VTv Therapeutics' financial success or failures. It also enables traders to predict the movement of VTv Stock. The fundamental analysis module provides a way to measure VTv Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VTv Therapeutics stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 9 K | 8.6 K |
VTv | Revenue |
vTv Therapeutics Company Revenue Analysis
VTv Therapeutics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current VTv Therapeutics Revenue | 9 K |
Most of VTv Therapeutics' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, vTv Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of VTv
Projected quarterly revenue analysis of vTv Therapeutics provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of VTv Therapeutics match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in VTv Therapeutics' stock price.
VTv Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for VTv Therapeutics is extremely important. It helps to project a fair market value of VTv Stock properly, considering its historical fundamentals such as Revenue. Since VTv Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of VTv Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of VTv Therapeutics' interrelated accounts and indicators.
| -0.03 | 0.37 | -0.22 | -0.25 | -0.74 | ||
| -0.03 | -0.16 | 0.48 | 0.44 | 0.4 | ||
| 0.37 | -0.16 | -0.79 | -0.56 | -0.66 | ||
| -0.22 | 0.48 | -0.79 | 0.61 | 0.68 | ||
| -0.25 | 0.44 | -0.56 | 0.61 | 0.47 | ||
| -0.74 | 0.4 | -0.66 | 0.68 | 0.47 |
Click cells to compare fundamentals
VTv Revenue Historical Pattern
Today, most investors in VTv Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various VTv Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of VTv Therapeutics revenue as a starting point in their analysis.
VTv Therapeutics Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
VTv Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, vTv Therapeutics reported 9 K of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
vTv Therapeutics is rated second in revenue category among related companies. Market size based on revenue of Health Care industry is at this time estimated at about 380.8 Million. VTv Therapeutics adds roughly 9,000 in revenue claiming only tiny portion of equities under Health Care industry.VTv Therapeutics Institutional Holders
Institutional Holdings refers to the ownership stake in VTv Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of VTv Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing VTv Therapeutics' value.| Shares | Cornerstone Planning Group Llc | 2023-12-31 | 19.0 | Sunbelt Securities | 2023-12-31 | 15.0 | Jpmorgan Chase & Co | 2023-12-31 | 1.0 | Bank Of America Corp | 2023-12-31 | 1.0 | State Street Corporation | 2023-12-31 | 0.0 | Susquehanna International Group, Llp | 2023-12-31 | 0.0 | Northern Trust Corp | 2023-12-31 | 0.0 | Millennium Management Llc | 2023-12-31 | 0.0 | Bnp Paribas Arbitrage, Sa | 2023-12-31 | 0.0 | Pathstone Family Office, Llc | 2023-09-30 | 242.9 K | Samsara Biocapital, Llc | 2023-12-31 | 40.9 K |
VTv Fundamentals
| Return On Equity | -49.78 | ||||
| Return On Asset | -0.72 | ||||
| Current Valuation | 59.19 M | ||||
| Shares Outstanding | 2.43 M | ||||
| Shares Owned By Insiders | 54.68 % | ||||
| Shares Owned By Institutions | 16.05 % | ||||
| Number Of Shares Shorted | 28.84 K | ||||
| Price To Earning | (4.19) X | ||||
| Price To Sales | 3,631 X | ||||
| Revenue | 9 K | ||||
| Gross Profit | (9.93 M) | ||||
| EBITDA | (25.41 M) | ||||
| Net Income | (20.25 M) | ||||
| Cash And Equivalents | 17.95 M | ||||
| Cash Per Share | 0.22 X | ||||
| Total Debt | 529 K | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 3.12 X | ||||
| Book Value Per Share | (11.84) X | ||||
| Cash Flow From Operations | (18.52 M) | ||||
| Short Ratio | 1.70 X | ||||
| Earnings Per Share | (9.71) X | ||||
| Target Price | 2.0 | ||||
| Number Of Employees | 16 | ||||
| Beta | 0.58 | ||||
| Market Capitalization | 61.98 M | ||||
| Total Asset | 11.02 M | ||||
| Retained Earnings | (281.04 M) | ||||
| Working Capital | 38 K | ||||
| Current Asset | 52.12 M | ||||
| Current Liabilities | 10.58 M | ||||
| Net Asset | 11.02 M |
About VTv Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze vTv Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VTv Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of vTv Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VTv Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VTv Therapeutics' short interest history, or implied volatility extrapolated from VTv Therapeutics options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether vTv Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if VTv Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Vtv Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Vtv Therapeutics Stock:Check out VTv Therapeutics Piotroski F Score and VTv Therapeutics Altman Z Score analysis. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for VTv Stock analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is VTv Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.71) | Revenue Per Share 0.004 | Return On Assets (0.72) | Return On Equity (49.78) |
The market value of vTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.